Zoetis Inc. Short-term Debt, Weighted Average Interest Rate, at Point in Time
Zoetis Inc. (ZTS) had Short-term Debt, Weighted Average Interest Rate, at Point in Time of 5.20% as of 2016-12-31, per its 10-K filed 2017-02-16.
Discontinued › Notes › Debt
us-gaap:ShortTermDebtWeightedAverageInterestRate · last filed 2017-02-16
- 2016-12-31: Short-term Debt, Weighted Average Interest Rate, at Point in Time 5.20%.
- 2016-07-03: Short-term Debt, Weighted Average Interest Rate, at Point in Time 5.40%.
- 2016-04-03: Short-term Debt, Weighted Average Interest Rate, at Point in Time 5.40%.
- 2015-12-31: Short-term Debt, Weighted Average Interest Rate, at Point in Time 5.20%.
| Period end | Short-term Debt, Weighted Average Interest Rate, at Point in Time | Short-term Debt, Weighted Average Interest Rate, at Point in Time as first filed |
|---|---|---|
| 2016-12-31 | 5.20% 10-K · filed 2017-02-16 | |
| 2016-07-03 | 5.40% 10-Q · filed 2016-08-05 | |
| 2016-04-03 | 5.40% 10-Q · filed 2016-05-06 | |
| 2015-12-31 | 5.20% 10-Q · filed 2016-11-03 | |
| 2015-09-27 | 6.00% 10-Q · filed 2015-11-05 | |
| 2015-06-28 | 6.40% 10-Q · filed 2015-08-06 | |
| 2015-03-29 | 9.70% 10-Q · filed 2015-05-07 | |
| 2014-12-31 | 9.70% 10-K · filed 2016-02-24 | 7.80% 10-K · filed 2015-02-27 |
| 2014-09-28 | 8.00% 10-Q · filed 2014-11-10 | |
| 2014-06-29 | 8.30% 10-Q · filed 2014-08-12 | |
| 2014-03-30 | 7.20% 10-Q · filed 2014-05-13 | |
| 2013-12-31 | 5.70% 10-K · filed 2015-02-27 | |
| 2013-09-29 | 5.40% 10-Q · filed 2013-11-13 | |
| 2013-06-30 | 4.60% 10-Q · filed 2013-08-14 | |
| 2013-03-31 | 3.00% 10-Q · filed 2013-05-15 | |
| 2012-12-31 | 3.70% 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |